Lucid Diagnostics (LUCD) Competitors $1.03 -0.04 (-3.74%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.06 +0.03 (+3.40%) As of 09/12/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUCD vs. AVNS, ZIMV, KIDS, TMCI, CBLL, SMLR, DCTH, BFLY, RXST, and CARLShould you be buying Lucid Diagnostics stock or one of its competitors? The main competitors of Lucid Diagnostics include AVANOS MEDICAL (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), CeriBell (CBLL), Semler Scientific (SMLR), Delcath Systems (DCTH), Butterfly Network (BFLY), RxSight (RXST), and Carlsmed (CARL). These companies are all part of the "medical equipment" industry. Lucid Diagnostics vs. Its Competitors AVANOS MEDICAL ZimVie OrthoPediatrics Treace Medical Concepts CeriBell Semler Scientific Delcath Systems Butterfly Network RxSight Carlsmed Avanos Medical (NYSE:AVNS) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk. Is AVNS or LUCD more profitable? Avanos Medical has a net margin of -66.89% compared to Lucid Diagnostics' net margin of -1,476.35%. Avanos Medical's return on equity of 6.16% beat Lucid Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Avanos Medical-66.89% 6.16% 4.57% Lucid Diagnostics -1,476.35%N/A -120.43% Do institutionals and insiders believe in AVNS or LUCD? 95.2% of Avanos Medical shares are held by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are held by institutional investors. 2.6% of Avanos Medical shares are held by insiders. Comparatively, 6.8% of Lucid Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts recommend AVNS or LUCD? Lucid Diagnostics has a consensus target price of $3.65, indicating a potential upside of 254.37%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe Lucid Diagnostics is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to AVNS or LUCD? In the previous week, Lucid Diagnostics had 8 more articles in the media than Avanos Medical. MarketBeat recorded 11 mentions for Lucid Diagnostics and 3 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.35 beat Lucid Diagnostics' score of 0.58 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lucid Diagnostics 2 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, AVNS or LUCD? Lucid Diagnostics has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvanos Medical$692.50M0.82-$392.10M-$10.07-1.21Lucid Diagnostics$4.35M25.69-$45.53M-$1.19-0.87 Which has more risk and volatility, AVNS or LUCD? Avanos Medical has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500. SummaryLucid Diagnostics beats Avanos Medical on 10 of the 16 factors compared between the two stocks. Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LUCD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUCD vs. The Competition Export to ExcelMetricLucid DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$116.07M$6.95B$5.87B$10.14BDividend YieldN/A1.21%5.68%4.59%P/E Ratio-0.8725.5274.5225.93Price / Sales25.69192.52548.33126.97Price / CashN/A22.1337.5660.44Price / Book-1.325.0012.166.29Net Income-$45.53M$176.38M$3.28B$270.77M7 Day Performance-24.82%1.00%0.87%3.88%1 Month Performance4.98%0.74%4.96%4.88%1 Year Performance21.72%10.34%60.74%26.01% Lucid Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUCDLucid Diagnostics3.1686 of 5 stars$1.03-3.7%$3.65+254.4%+23.3%$116.07M$4.35M-0.8770News CoverageAVNSAVANOS MEDICAL2.1375 of 5 stars$12.41-2.5%N/A-48.0%$590.24M$687.80M-1.232,227Positive NewsZIMVZimVie1.2491 of 5 stars$18.89+0.2%$17.75-6.0%+16.2%$531.77M$449.75M-26.991,770News CoveragePositive NewsKIDSOrthoPediatrics4.3497 of 5 stars$20.91flat$34.14+63.3%-37.8%$524.29M$204.73M-11.68200News CoveragePositive NewsTMCITreace Medical Concepts2.523 of 5 stars$7.11-0.8%$9.83+38.3%+42.7%$452.95M$209.36M-9.00250Positive NewsCBLLCeriBell2.5129 of 5 stars$12.06+2.2%$32.14+166.5%N/A$432.64M$65.44M-4.03N/APositive NewsSMLRSemler Scientific2.9788 of 5 stars$28.29+0.6%$81.75+189.0%+18.7%$416.31M$56.29M11.64120DCTHDelcath Systems2.9841 of 5 stars$11.55-0.9%$24.50+112.1%+10.5%$407.53M$37.21M231.0060Positive NewsBFLYButterfly Network3.1579 of 5 stars$1.60+2.2%$3.00+88.1%-17.6%$392.72M$82.06M-5.70460RXSTRxSight1.8641 of 5 stars$8.94+0.6%$10.00+11.9%-82.9%$363.74M$139.93M-11.18220Trending NewsCARLCarlsmedN/A$13.38+5.0%N/AN/A$338.64MN/A0.00100Negative News Related Companies and Tools Related Companies AVNS Alternatives ZIMV Alternatives KIDS Alternatives TMCI Alternatives CBLL Alternatives SMLR Alternatives DCTH Alternatives BFLY Alternatives RXST Alternatives CARL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUCD) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LUCD Stock Alerts